Dementia Reversal?
Patient
one: therapeutic program
As noted above, and following an extended discussion of the
components of the therapeutic program, the patient began on some but not all
of the system:
-
she
eliminated all simple
carbohydrates, leading to a weight loss of 20 pounds;
-
eliminated gluten and processed food from her
diet, and increased vegetables, fruits, and
non-farmed fish;
-
in order to reduce stress, she began yoga, and ultimately
became a yoga instructor;
-
as a second measure to reduce the stress of her job, she
began to meditate for 20 minutes twice per day;
-
melatonin 0.5mg po qhs;
-
increased her sleep from 4-5 hours per night
to 7-8 hours per night;
-
methylcobalamin 1mg each day;
-
vitamin D3 2000IU each day;
-
fish oil 2000mg each day;
-
CoQ10 200mg each day;
-
optimized her oral hygiene using an electric flosser and
electric toothbrush;
-
following discussion with her primary care provider, she
reinstated HRT (hormone replacement therapy) that had been discontinued
following the WHI report in 2002;
-
fasted for a minimum of 12 hours between
dinner and breakfast, and for a minimum of three hours between dinner and
bedtime;
-
exercised for a minimum of 30 minutes, 4-6
days per week.
The Full
Report for all 10 patients
Of the first 10 patients who utilized this program,
including patients with memory loss associated with Alzheimer's disease
(AD), amnestic mild cognitive impairment (aMCI), or subjective cognitive
impairment (SCI), nine showed subjective or objective improvement.
•One potentially important outcome is that all six of
the patients whose cognitive decline had a major impact on job performance
were able to return to work or continue working without difficulty. |
Patient one: history
A 67-year-old woman presented with two years of progressive
memory loss. She held a demanding job that involved preparing analytical
reports and traveling widely, but found herself no longer able to analyze
data or prepare the reports, and therefore was forced to consider quitting
her job. She noted that when she would read, by the time she reached the
bottom of a page she would have to start at the top once again, since she
was unable to remember the material she had just read. She was no longer
able to remember numbers, and had to write down even 4-digit numbers to
remember them. She also began to have trouble navigating on the road: even
on familiar roads, she would become lost trying to figure out where to enter
or exit the road. She also noticed that she would mix up the names of her
pets, and forget where the light switches were in her home of years.
Her mother had developed similar progressive cognitive
decline beginning in her early 60s, had become severely demented, entered a
nursing home, and died at approximately 80 years of age. When the patient
consulted her physician about her problems, she was told that she had the
same problem her mother had had, and that there was nothing he could do
about it. He wrote “memory problems” in her chart, and therefore the patient
was turned down in her application for long- term care.
After being informed that she had the same problem as her
mother had had, she recalled the many years of her mother’s decline in a
nursing home. Knowing that there was still no effective treatment and
subsequently losing the ability to purchase long-term care, she decided to
commit suicide. She called a friend to commiserate, who suggested that she
get on a plane and visit, and then referred her for evaluation.
She began System 1.0 (Table 1), and was able to adhere to
some but not all of the protocol components. Nonetheless,
after three months she noted that all of her symptoms
had abated: she was able to navigate without problems, remember telephone
numbers without difficulty, prepare reports and do all of her work without
difficulty, read and retain information, and, overall, she became
asymptomatic. She noted that her memory was now better than it had been in
many years. On one occasion, she developed an acute viral illness,
discontinued the program, and noticed a decline, which reversed when she
reinstated the program. Two and one-half years later, now age 70, she
remains asymptomatic and continues to work full-time. |
Patient
two: therapeutic program
The patient began on the following parts of the overall
therapeutic system:
-
he
fasted for a minimum of three hours between
dinner and bedtime, and for a minimum of 12 hours between dinner and
breakfast;
-
eliminated simple
carbohydrates and processed foods from
his diet;
-
increased consumption of vegetables and fruits, and limited consumption of
fish to non-farmed,
and meat to occasional grass-fed beef or organic chicken;
-
probiotics;
-
coconut oil i tsp bid;
-
exercised strenuously, swimming 3-4 times per
week, cycling twice per week, and running once per week;
-
melatonin 0.5mg po qhs, and tried to
sleep as close to 8 hours per night as his
schedule would allow;
-
herbs Bacopa monniera 250mg, Ashwagandha
500mg, and turmeric 400mg each day;
-
methylcobalamin 1mg, methyltetrahydrofolate 0.8mg, and
pyridoxine-5- phosphate 50mg each day;
-
citicoline 500mg po bid;
-
vitamin C 1g per day, vitamin D3 5000IU per day, vitamin E
400IU per day, CoQ10 200mg per day, Zn picolinate
50mg per day, and -lipoic acid 100mg per day;
-
DHA (docosahexaenoic acid) 320mg and EPA (eicosapentaenoic
acid) 180mg per day
|
Patient two: history
A 69-year-old entrepreneur and professional man presented
with 11 years of slowly progressive memory loss, which had accelerated over
the past one or two years. In 2002, at the age of 58, he had been unable to
recall the combination of the lock on his locker, and he felt that this was
out of the ordinary for him. In 2003, he had FDG-PET (fluoro-deoxyglucose
positron emission tomography), which was read as showing a pattern typical
for early Alzheimer’s disease, with reduced glucose utilization in the
parietotemporal cortices bilaterally and left > right temporal lobes, but
preserved utilization in the frontal lobes, occipital cortices, and basal
ganglia. In 2003, 2007, and 2013, he had quantitative neuropsychological
testing, which showed a reduction in CVLT (California Verbal Learning Test)
from 84%ile to 1%ile, a Stroop color test at 16%ile, and auditory delayed
memory at 13%ile. In 2013, he was found to be heterozygous for ApoE4 (3/4).
He noted that he had progressive difficulty recognizing the faces at work (prosopagnosia),
and had to have his assistants prompt him with the daily schedule. He also
recalled an event during which he was several chapters into a book before he
finally realized that it was a book he had read previously. In addition, he
lost an ability he had had for most of his life: the ability to add columns
of numbers rapidly in his head.
He had a homocysteine of 18 mol/l,
CRP <0.5mg/l, 25- OH cholecalciferol 28ng/ml, hemoglobin A1c 5.4%, serum
zinc 78mcg/dl, serum copper 120mcg/dl, ceru- loplasmin 25mg/dl, pregnenolone
6ng/dl, testosterone 610ng/dl, albumin:globulin ratio of 1.3, cholesterol
165mg/dl (on Lipitor), HDL 92, LDL 64, triglyceride 47, AM cortisol
14mcg/dl, free T3 3.02pg/ml, free T4 1.27ng/l, TSH 0.58mIU/l, and BMI 24.9.
He began on the therapeutic program, and
after six months, his wife, co-workers, and he all
noted improvement. He lost 10 pounds. He was able to recognize faces at work
unlike before, was able to remember his daily schedule, and was able to
function at work without difficulty. He was also noted to be quicker with
his responses. His life-long ability to add columns of numbers rapidly in
his head, which he had lost during his progressive cognitive decline,
returned. His wife pointed out that, although he had clearly shown
improvement, the more striking effect was that he had been accelerating in
his decline over the prior year or two, and this had been completely halted. |
Patient
three: therapeutic program
She began on
the following parts of the therapeutic system:
-
she
fasted for a minimum of three hours between dinner and bedtime, and
for a minimum of 12 hours between dinner and breakfast;
-
eliminated simple carbohydrates and
processed foods from her diet;
-
increased consumption of
vegetables and fruits, limited consumption of fish to
non-farmed, and did not eat meat;
-
exercised 4-5 times per week;
-
melatonin
0.5mg po qhs, and tried to sleep as
close to 8 hours per night as her schedule would allow;
-
she tried to
reduce stress in her life with meditation and relaxation;
-
methylcobalamin 1mg 4x/wk and pyridoxine-5-phosphate 20mg each day;
-
citicoline
200mg each day;
-
vitamin D3
2000IU per day and CoQ10 200mg per day;
-
DHA 700mg and
EPA 500mg bid;
-
her primary
care provider prescribed bioidentical estradiol with estriol (BIEST), and
progesterone;
-
her primary
care provider worked with her to reduce her bupropion from 150mg per day
to 150mg 3x/wk.
|
Patient three: history
A 55-year-old attorney suffered progressively severe memory
loss for four years. She accidentally left the stove on when she left her
home on multiple occasions, and then returned, horrified to see that she had
left it on once again. She would forget meetings, and agree to multiple
meetings at the same time. Because of an inability to remember anything
after a delay, she would record conversations, and she carried an iPad on
which she took copious notes (but then forgot the password to unlock her
iPad). She had been trying to learn Spanish as part of her job, but was
unable to remember virtually anything new. She was unable to perform her
job, and she sat her children down to explain to them that they could no
longer take advantage of her poor memory, that instead they must understand
that her memory loss was a serious problem. Her children noted that she
frequently became lost in mid-sentence, that she was slow with responses,
and that she frequently asked if they had followed up on something she
thought she had asked them to do, when in fact she had never asked them to
do the tasks to which she referred.
Her homocysteine was 9.8mol/l, CRP
0.16mg/l, 25- OH cholecalciferol 46ng/ml, hemoglobin A1c 5.3%, pregnenolone
84ng/dl, DHEA 169ng/dl, estradiol 275pg/ml, progesterone 0.4ng/ml, insulin
2.7IU/ml, AM cortisol 16.3mcg/dl, free T3
3.02pg/ml, free T4 1.32ng/l, and TSH 2.04mIU/l.
After five months on the therapeutic program, she
noted that she no longer needed her iPad for notes, and no longer needed to
record conversations. She was able to work once again, was able to learn
Spanish, and began to learn a new legal specialty. Her children noted that
she no longer became lost in mid-sentence, no longer thought she had asked
them to do something that she had not asked, and answered their questions
with normal rapidity and memory. |
Patient
me:
Cos I hate vegetables so much
-- I buy :-
Bulk lettuce, spinach, asparagus, onion, mushroom, beetroot, broccoli.
Add tinned beans ( garbanzo, kidney, black, butter, refried, peas).
Add meat from a whole cooked chicken ($5 from COSTCO).
No more processed meat.
--- Add a tinned soup ( tomato or chicken broth) and microwave it
or
--- Add microwaved beans + soup and put everything into a food mixer .
NO MORE:- potatoes, rice, pasta, soy, corn,
processed meat, cheese and GRAINS( all bread, cereal, pancakes,
cookies etc...)
Almost all my carbs come from beans and cashews.
My only source of sugar(fructose) is
fresh fruit and what they sneak into tinned
foods like tomato soup and sweet peas.
All pretty drastic but necessary. I call it the Caveman's
Natural Lifestyle .
(Paleo Diet:- but includes fat-free milk, cashew nuts, lentils, beans, peas
and all other legumes and excludes honey). |
lost 45 lbs (from 230lbs to 185lbs) |
Table 1. Therapeutic System 1.0
Goal |
Approach |
Rationale and References |
Optimize diet: minimize simple CHO, minimize inflammation. |
Patients given choice of several low glycemic, low inflammatory, low grain
diets. |
Minimize inflammation, minimize insulin resistance. |
Enhance autophagy, ketogenesis |
Fast 12 hrs each night, including 3 hrs prior
to bedtime. |
Reduce insulin levels, reduce A. |
Reduce stress |
Personalized—yoga or meditation or music, etc. |
Reduction of cortisol, CRF, stress axis. |
Optimize sleep |
8 hr sleep per night; melatonin 0.5mg po qhs;
Trp 500mg po 3x/wk if awakening. Exclude sleep
apnea. |
[36] |
Exercise |
30-60’ per day, 4-6 days/wk |
[37, 38] |
Brain stimulation |
Posit or related |
[39] |
Homocysteine <7 |
Me-B12, MTHF, P5P; TMG if necessary |
[40] |
Serum B12 >500 |
Me-B12 |
[41] |
CRP <1.0; A/G >1.5 |
Anti-inflammatory diet; curcumin; DHA/EPA; optimize hygiene |
Critical role of inflammation in AD |
Fasting insulin <7; HgbA1c <5.5 |
Diet as above |
Type II diabetes-AD relationship |
Hormone balance |
Optimize fT3, fT4, E2, T, progesterone, pregnenolone,
cortisol |
[5, 42] |
GI health |
Repair if needed; prebiotics and probiotics |
Avoid inflammation, autoimmunity |
Reduction of A-beta |
Curcumin, Ashwagandha |
[43-45] |
Cognitive enhancement |
Bacopa monniera, MgT |
[46, 47] |
25OH-D3 = 50-100ng/ml |
Vitamins D3, K2 |
[48] |
Increase NGF |
H. erinaceus or ALCAR |
[49, 50] |
Provide synaptic structural components |
Citicoline, DHA |
[51]. |
Optimize antioxidants |
Mixed tocopherols and tocotrienols, Se, blueberries, NAC,
ascorbate, -lipoic acid |
[52] |
Optimize Zn:fCu ratio |
Depends on values obtained |
[53] |
Ensure nocturnal oxygenation |
Exclude or treat sleep apnea |
[54] |
Optimize mitochondrial function |
CoQ or ubiquinol, -lipoic acid, PQQ,
NAC, ALCAR, Se,
Zn, resveratrol, ascorbate, thiamine |
[55] |
Increase focus |
Pantothenic acid |
Acetylcholine synthesis requirement |
Increase SirT1 function |
Resveratrol |
[32] |
Exclude heavy metal toxicity |
Evaluate Hg, Pb, Cd; chelate if indicated |
CNS effects of heavy metals |
MCT effects |
Coconut oil or Axona |
[56] |
CHO, carbohydrates; Hg, mercury; Pb, lead; Cd, cadmium; MCT, medium chain
triglycerides; PQQ, polyquinoline quinone; NAC, N‐acetyl cysteine; CoQ, coenzyme
Q; ALCAR, acetyl‐L‐carnitine; DHA, docosahexaenoic acid; MgT, magnesium
threonate; fT3, free triiodothyronine; fT4, free thyroxine; E2, estradiol; T,
testosterone; Me‐B12, methylcobalamin; MTHF, methyltetrahydrofolate; P5P,
pyridoxal‐5‐phosphate; TMG, trimethylglycine; Trp, tryptophan
SOURCE Buck
Institute or
source on this site
|